skip to primary navigationskip to content

Cambridge Infectious Diseases

An Interdisciplinary Research Centre at the University of Cambridge

Studying at Cambridge


Interdisciplinary Infectious Disease Research

Sparking and sharing new knowledge to prevent, manage and treat infectious diseases worldwide.

Infectious diseases are a leading cause of mortality worldwide and a major threat to our food supply and natural resources—particularly with the emergence of new and invasive pathogens. As one of the World’s leading Universities, Cambridge and its partner institutes and industrial collaborators, are already known for academic excellence in infectious disease research and related fields, particularly in Medicine and Chemistry, where screening of large chemical libraries is leading to new developments in antimicrobial therapies. As an Interdisciplinary Research Centre Cambridge Infectious Diseases (CID) is working to capitalise on and extend this expertise by creating novel research through bridging disciplines working on infectious diseases.

Find out how our researchers are harnessing collaborative advantage and tackling the global grand research challenge of reducing the burden of infectious diseases by exploring key programmes.

  • Pathogen Biology and Evolution. Evolution is a key aspect of the biology of many pathogens, driving processes ranging from immune escape to changes in virulence. 
  • Host-Pathogen Interactions. Understanding the mechanisms of pathogenesis caused by bacteria, viruses and parasites plays a key role in understanding infectious diseases. 
  • Infectious Disease Dynamics. Epidemiology and Mathematical Modelling provide vital mathematical and statistical tools to study the spatial spread of epidemics in populations. 
  • Drugs and Vaccines. Vaccines and the discovery of new antimicrobial drugs are one of our most effective means for controlling infectious diseases. 

  • Infectious Diseases Technology. Enabling innovation and access to health technologies remains a key strategy in combating infectious diseases in low- and middle-income countries (LMICs). 



Professor Ian Goodfellow speaks about Ebola laboratory capacity building and science outreach supported by CID

Ethicobots discusses bTB control strategies in Ethiopia